agen1884

mAbexperimental

Clinical trial activity

11 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
8
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2016 (NCT02694822)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2017

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • agen1884

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05033132Phase 2Sep 28, 2021Agenus Inc., Betta Pharmaceuticals Co.,Ltd.
NCT04827953Phase 1/Phase 2 (Phase 2)Sep 1, 2021Agenus Inc., Apices Soluciones S.L., Nelum Corp, Universidad Autonoma de Barcelona
NCT04943848Phase 1Jul 31, 2021Harvard University, Northwestern University, University of California, Irvine
NCT04607200Phase 2Dec 31, 2020Agenus Inc.
NCT04430036Phase 2Aug 31, 2020University of Texas, San Antonio
NCT04028063Phase 2Aug 31, 2019Agenus Inc., National Cancer Institute (NCI), University of Colorado, Denver
NCT03894215Phase 2May 31, 2019Agenus Inc.
NCT03495882Phase 1/Phase 2 (Phase 2)Dec 18, 2017Agenus Inc., ICON
NCT03411473Phase 2Oct 4, 2017Agenus Inc.
NCT02694822Phase 1Apr 1, 2016Agenus Inc.
NCT05572970N/AAgenus Inc.
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Agenus Inc.For profit9732016
Apices Soluciones S.L.For profit1012021
Betta Pharmaceuticals Co.,Ltd.For profit1012021
Harvard UniversityAcademic/Hospital1012021
ICONFor profit1012017
National Cancer Institute (NCI)Government1012019
Nelum CorpFor profit1112021
Northwestern UniversityAcademic/Hospital1112021
Universidad Autonoma de BarcelonaAcademic/Hospital1012021
University of California, IrvineAcademic/Hospital1012021
University of Colorado, DenverAcademic/Hospital1112019
University of Texas, San AntonioAcademic/Hospital1112020
12 organizations
Page 1 / 1